Studies

Defining the therapeutic potential of CD25 (IL2-R) blockade as a novel treatment for genetically stratified Crohn’s disease patients

Speciality area
Gastroenterology

Study type
Participant re-contact

Researcher type
Academic

Research lead
Professor Graham Lord

HICC: Humoral Immune Correlates for COVID19: Defining protective Ab responses and critical readouts for Clinical Trials of Vaccines and Therapeutics

Speciality area
Infection, COVID

Study type
Participant re-contact

Researcher type
Academic

Research lead
Dr Helen Baxendale

Monogenic immune deficiency diseases

Speciality area
Genomics and Rare Diseases

Study type
Data only

Researcher type
Academic

Research lead
Manish Butte

Testing biotx.ai's AI for wide data in Rare Diseases

Speciality area
Genomics and Rare Diseases

Study type
Data only

Researcher type
Commercial

Research lead
Marco Schmidt

Can Covid-19 outcome be revealed by single cell analysis?

Speciality area
Infection, COVID

Study type
Data only

Researcher type
Academic

Research lead
Paul Lyons

IBD drug therapies and COVID-19

Speciality area
Gastroenterology, Infection, COVID

Study type
Data only

Researcher type
Academic

Research lead
Nick Kennedy

Investigation of the underlying genetic variation of idiopathic and heritable pulmonary arterial hypertension (PAH)

Speciality area
Genomics and Rare Diseases, Cardiovascular Disease

Study type
Data only

Researcher type
Academic

Research lead
Dr Stefan Gräf

CLARITY: impaCt of bioLogic therApy on saRs-cov-2 Infection and immuniTY

Speciality area
Infection, COVID

Study type
Participant re-contact

Researcher type
Academic

Research lead
Dr Tariq Ahmad

TRACK-COVID: a population-based epidemiological investigation of COVID-19 virus infection

Speciality area
Cross-cutting, COVID

Study type
Participant re-contact

Researcher type
Academic

Research lead
Professor Emanuele Di Angelantonio